State of Wisconsin Investment Board’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $941K | Sell |
27,810
-6,827
| -20% | -$194K | ﹤0.01% | 1721 |
|
|
2025
Q4 | $943K | Sell |
34,637
-936
| -3% | -$32.8K | ﹤0.01% | 1705 |
|
|
2025
Q3 | $1.43M | Sell |
35,573
-23,527
| -40% | -$885K | ﹤0.01% | 1483 |
|
|
2025
Q2 | $1.97M | Sell |
59,100
-10,584
| -15% | -$321K | ﹤0.01% | 1306 |
|
|
2025
Q1 | $2.04M | Buy |
69,684
+1,363
| +2% | +$45.2K | 0.01% | 1235 |
|
|
2024
Q4 | $2.25M | Buy |
68,321
+35,860
| +110% | +$1.68M | 0.01% | 1246 |
|
|
2024
Q3 | $1.44M | Sell |
32,461
-4,037
| -11% | -$183K | ﹤0.01% | 1443 |
|
|
2024
Q2 | $1.57M | Sell |
36,498
-320
| -0.9% | -$11.5K | ﹤0.01% | 1399 |
|
|
2024
Q1 | $1.08M | Sell |
36,818
-4,734
| -11% | -$127K | ﹤0.01% | 1410 |
|
|
2023
Q4 | $925K | Sell |
41,552
-572
| -1% | -$12.8K | ﹤0.01% | 1416 |
|
|
2023
Q3 | $1.04M | Sell |
42,124
-1,615
| -4% | -$42.7K | ﹤0.01% | 1380 |
|
|
2023
Q2 | $1.24M | Sell |
43,739
-1,864
| -4% | -$46.4K | ﹤0.01% | 1409 |
|
|
2023
Q1 | $1.05M | Sell |
45,603
-2,449
| -5% | -$65K | ﹤0.01% | 1465 |
|
|
2022
Q4 | $1.35M | Sell |
48,052
-1,645
| -3% | -$46.4K | ﹤0.01% | 1414 |
|
|
2022
Q3 | $1.41M | Sell |
49,697
-3,562
| -7% | -$95.5K | ﹤0.01% | 1432 |
|
|
2022
Q2 | $1.18M | Sell |
53,259
-26,641
| -33% | -$602K | ﹤0.01% | 1541 |
|
|
2022
Q1 | $2.33M | Hold |
79,900
| – | – | ﹤0.01% | 1453 |
|
|
2021
Q4 | $2.63M | Hold |
79,900
| – | – | 0.01% | 1201 |
|
|
2021
Q3 | $3.69M | Hold |
79,900
| – | – | 0.01% | 1132 |
|
|
2021
Q2 | $4.4M | Buy |
79,900
+72,110
| +926% | +$4.03M | 0.01% | 1087 |
|
|
2021
Q1 | $402K | Sell |
7,790
-115
| -1% | -$5.7K | ﹤0.01% | 1654 |
|
|
2020
Q4 | $343K | Sell |
7,905
-330
| -4% | -$13K | ﹤0.01% | 1656 |
|
|
2020
Q3 | $288K | Buy |
8,235
+160
| +2% | +$7.01K | ﹤0.01% | 1844 |
|
|
2020
Q2 | $432K | Sell |
8,075
-70
| -0.9% | -$3.24K | ﹤0.01% | 1472 |
|
|
2020
Q1 | $289K | Sell |
8,145
-400
| -5% | -$18.5K | ﹤0.01% | 1506 |
|
|
2019
Q4 | $408K | Buy |
8,545
+1,240
| +17% | +$46.9K | ﹤0.01% | 1490 |
|
|
2019
Q3 | $237K | Sell |
7,305
-55
| -0.7% | -$2.28K | ﹤0.01% | 1488 |
|
|
2019
Q2 | $367K | Sell |
7,360
-2,066
| -22% | -$110K | ﹤0.01% | 1399 |
|
|
2019
Q1 | $636K | Sell |
9,426
-280
| -3% | -$16.3K | ﹤0.01% | 1284 |
|
|
2018
Q4 | $448K | Hold |
9,706
| – | – | ﹤0.01% | 1344 |
|
|
2018
Q3 | $749K | Sell |
9,706
-225
| -2% | -$18.1K | ﹤0.01% | 1295 |
|
|
2018
Q2 | $836K | Buy |
9,931
+27
| +0.3% | +$2.35K | ﹤0.01% | 1230 |
|
|
2018
Q1 | $810K | Buy |
9,904
+1,345
| +16% | +$104K | ﹤0.01% | 1188 |
|
|
2017
Q4 | $489K | Buy |
8,559
+110
| +1% | +$6.92K | ﹤0.01% | 1304 |
|
|
2017
Q3 | $564K | Buy |
8,449
+175
| +2% | +$10.5K | ﹤0.01% | 1267 |
|
|
2017
Q2 | $426K | Buy |
8,274
+2,080
| +34% | +$106K | ﹤0.01% | 1317 |
|
|
2017
Q1 | $362K | Sell |
6,194
-10,902
| -64% | -$523K | ﹤0.01% | 1237 |
|
|
2016
Q4 | $713K | Sell |
17,096
-2,674
| -14% | -$140K | ﹤0.01% | 1224 |
|
|
2016
Q3 | $1.04M | Buy |
19,770
+1,300
| +7% | +$56.6K | ﹤0.01% | 1242 |
|
|
2016
Q2 | $774K | Buy |
18,470
+600
| +3% | +$29.6K | ﹤0.01% | 1250 |
|
|
2016
Q1 | $726K | Sell |
17,870
-970
| -5% | -$41.5K | ﹤0.01% | 1240 |
|
|
2015
Q4 | $1.22M | Sell |
18,840
-450
| -2% | -$29.5K | ﹤0.01% | 1190 |
|
|
2015
Q3 | $1.36M | Sell |
19,290
-510
| -3% | -$49.8K | 0.01% | 1203 |
|
|
2015
Q2 | $2.2M | Buy |
+19,800
| New | +$2.13M | 0.01% | 1160 |
|
Other funds holding AGIO
FCM
AC
VCM
LCM
VPM
EAM
State of Wisconsin Investment Board's AGIO Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Agios Pharmaceuticals (AGIO) stake by 20% in Q1 2026, selling an estimated $194K and leaving 27,810 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.
State of Wisconsin Investment Board first reported a position in AGIO in Q2 2015 and has held it in 44 quarters since. The position peaked at $4.4M in Q2 2021. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.
- State of Wisconsin Investment Board held 27,810 shares of Agios Pharmaceuticals worth $941K as of Q1 2026.
- State of Wisconsin Investment Board sold 6,827 Agios Pharmaceuticals shares in Q1 2026, an estimated $194K.
- Agios Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1721 holding.
- State of Wisconsin Investment Board first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
- State of Wisconsin Investment Board's Agios Pharmaceuticals position peaked at $4.4M in Q2 2021.
- 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.